BlackRock Advisors’s Halozyme HALO Stock Holding History

BlackRock Advisors’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$13.7M	Buy	1,390,733 +1,143,027	+461%	+$12.5M	0.01%	733
2016 Q3	$2.99M	Buy	247,706 +17,990	+8%	+$184K	﹤0.01%	1315
2016 Q2	$1.98M	Buy	229,716 +2,611	+1%	+$25.8K	﹤0.01%	1433
2016 Q1	$2.15M	Buy	227,105 +3,118	+1%	+$29.3K	﹤0.01%	1389
2015 Q4	$3.88M	Sell	223,987 -41,319	-16%	-$659K	﹤0.01%	1180
2015 Q3	$3.56M	Buy	265,306 +91,739	+53%	+$1.84M	﹤0.01%	1197
2015 Q2	$3.92M	Buy	173,567 +80,381	+86%	+$1.41M	﹤0.01%	1063
2015 Q1	$1.33M	Buy	93,186 +36,125	+63%	+$521K	﹤0.01%	1407
2014 Q4	$551K	Sell	57,061 -44,290	-44%	-$394K	﹤0.01%	1930
2014 Q3	$922K	Buy	101,351 +30,739	+44%	+$293K	﹤0.01%	1481
2014 Q2	$698K	Sell	70,612 -32,115	-31%	-$272K	﹤0.01%	1767
2014 Q1	$1.3M	Buy	102,727 +43,565	+74%	+$647K	﹤0.01%	1372
2013 Q4	$887K	Buy	59,162 +4,183	+8%	+$53.8K	﹤0.01%	1587
2013 Q3	$607K	Buy	54,979 +1,273	+2%	+$10.6K	﹤0.01%	1764
2013 Q2	$427K	Buy	+53,706	New	+$342K	﹤0.01%	1946

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock Advisors's HALO Position: Q4 2016 in Review

BlackRock Advisors increased its Halozyme (HALO) stake by 461% in Q4 2016, buying an estimated $12.5M and bringing the position to 1,390,733 shares worth $13.7M. The position accounts for 0.01% of the portfolio, ranked #733.

BlackRock Advisors first reported a position in HALO in Q2 2013 and has held it in 15 quarters since. 168 funds tracked by Wall St. Rank hold HALO as of Q4 2016.

BlackRock Advisors held 1,390,733 shares of Halozyme worth $13.7M as of Q4 2016.
BlackRock Advisors bought 1,143,027 Halozyme shares in Q4 2016, an estimated $12.5M.
Halozyme made up 0.01% of BlackRock Advisors's portfolio in Q4 2016, its #733 holding.
BlackRock Advisors first reported a position in Halozyme in Q2 2013 and has held it in 15 quarters since.
168 funds tracked by Wall St. Rank held Halozyme as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.